Hypopnea

Apr 17, 2020

Sleep Apnea Company Vivos Therapeutics Successfully Launches Online Training to Healthcare Professionals During Pandemic

Nov 13, 2019

Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program

Jun 18, 2019

Therapix Biosciences Announces Interim Results of Phase IIa Study at Assuta Medical Center for Obstructive Sleep Apnea Program

Apr 02, 2019

Dymedix Diagnostics Launches a Line of Purpose Built Pediatric Diagnostic Sleep Sensors called Lullaby

Nov 12, 2018

Nyxoah Raises EUR15 Million in New Financing, Completes BLAST OSA Clinical Study

Jun 25, 2018

FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea

Jun 05, 2018

Therapix Biosciences Announces Enrollment of the First Patient for Clinical Trial at Assuta Medical Center for Treating Obstructive Sleep Apnea Using Cannabinoid-based Drug

Feb 27, 2018

FDA Clears Innovative Treatment for Obstructive Sleep Disorders

Oct 24, 2017

Lianluo Smart Presents at the Summit Forum of Sleep Respiratory Diseases in Shandong Province

Oct 18, 2017

Therapix Biosciences and Assuta Medical Center to Initiate Clinical Trial in Obstructive Sleep Apnea

Oct 10, 2017

Respicardia's remed (R) System Receives FDA Approval

Oct 06, 2017

FDA approves implantable device to treat moderate to severe central sleep apnea